Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa study of odiparcil in adults with mucopolysaccharidosis type VI
2017-002158-35Phase 2Completed
- Sponsor
- Inventiva
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of odiparcil in mucopolysaccharidosis type VI (2 arms), sponsored by Inventiva. Primary endpoint: Preliminary safety assessment. Started Aug 2017; status: completed.
02
Drugs
odiparcil
03
Conditions
mucopolysaccharidosis type VI
Beyond the preview
Go deeper on 2017-002158-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002158-35.